These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10617087)

  • 21. Comparison of the metabolic effects of metformin and troglitazone on fructose-induced insulin resistance in male Sprague-Dawley rats.
    Chen CC; Wang HJ; Shih HC; Sheen LY; Chang CT; Chen RH; Wang TY
    J Formos Med Assoc; 2001 Mar; 100(3):176-80. PubMed ID: 11393112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Troglitazone, an euglycemic antidiabetic drug.
    Vyas K; Sivalakshmidevi A; Prabhakar C; Reddy GO
    Acta Crystallogr C; 1999 Mar; 55 ( Pt 3)():411-3. PubMed ID: 10220869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Troglitazone prevents glucose-induced insulin resistance of insulin receptor in rat-1 fibroblasts.
    Kellerer M; Kroder G; Tippmer S; Berti L; Kiehn R; Mosthaf L; Häring H
    Diabetes; 1994 Mar; 43(3):447-53. PubMed ID: 7508875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Troglitazone prevents and reverses dexamethasone induced insulin resistance on glycogen synthesis in 3T3 adipocytes.
    Anil Kumar KL; Marita AR
    Br J Pharmacol; 2000 May; 130(2):351-8. PubMed ID: 10807673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantification of the effects of troglitazone on insulin sensitivity and beta-cell function in Watanabe heritable hyperlipidemic rabbits: a minimal model analysis.
    Zhang B; Saku K; Arakawa K
    Metabolism; 1997 Mar; 46(3):273-81. PubMed ID: 9054469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Troglitazone and related compounds: therapeutic potential beyond diabetes.
    Fujiwara T; Horikoshi H
    Life Sci; 2000 Oct; 67(20):2405-16. PubMed ID: 11065164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of troglitazone on lipoprotein(a) levels in obese subjects.
    Tack CJ; Smits P; DeMacker PN; Stalenhoef AF
    Diabetes Care; 1999 Oct; 22(10):1752-3. PubMed ID: 10526754
    [No Abstract]   [Full Text] [Related]  

  • 28. Lipoatrophy, lipodystrophy, and insulin resistance.
    Ganda OP
    Ann Intern Med; 2000 Aug; 133(4):304-6. PubMed ID: 10929174
    [No Abstract]   [Full Text] [Related]  

  • 29. [Troglitazone for treatment of polycystic ovary syndrome].
    Sanaka M; Iwamoto Y
    Nihon Rinsho; 2000 Feb; 58(2):465-70. PubMed ID: 10707578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Troglitazone prevents hyperglycemia-induced but not glucosamine-induced insulin resistance.
    Miles PD; Higo K; Romeo OM; Lee MK; Rafaat K; Olefsky JM
    Diabetes; 1998 Mar; 47(3):395-400. PubMed ID: 9519745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Troglitazone: a review of its use in the management of type 2 diabetes mellitus.
    Plosker GL; Faulds D
    Drugs; 1999 Mar; 57(3):409-38. PubMed ID: 10193691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic effects of troglitazone on fat-induced insulin resistance in the rat.
    Khoursheed M; Miles PD; Gao KM; Lee MK; Moossa AR; Olefsky JM
    Metabolism; 1995 Nov; 44(11):1489-94. PubMed ID: 7476339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thiazolidinediones for type 2 diabetes. New agents reduce insulin resistance but need long term clinical trials.
    Krentz AJ; Bailey CJ; Melander A
    BMJ; 2000 Jul; 321(7256):252-3. PubMed ID: 10915108
    [No Abstract]   [Full Text] [Related]  

  • 34. Troglitazone (CS-045) ameliorates albuminuria in streptozotocin-induced diabetic rats.
    Fujii M; Takemura R; Yamaguchi M; Hasegawa G; Shigeta H; Nakano K; Kondo M
    Metabolism; 1997 Sep; 46(9):981-3. PubMed ID: 9284882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Troglitazone: an antidiabetic agent.
    Chen C
    Am J Health Syst Pharm; 1998 May; 55(9):905-25. PubMed ID: 9588250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone.
    Miles PD; Romeo OM; Higo K; Cohen A; Rafaat K; Olefsky JM
    Diabetes; 1997 Nov; 46(11):1678-83. PubMed ID: 9356012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat.
    Lee MK; Miles PD; Khoursheed M; Gao KM; Moossa AR; Olefsky JM
    Diabetes; 1994 Dec; 43(12):1435-9. PubMed ID: 7958495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of troglitazone and pioglitazone on cytokine-mediated endothelial cell proliferation in vitro.
    Gralinski MR; Rowse PE; Breider MA
    J Cardiovasc Pharmacol; 1998 Jun; 31(6):909-13. PubMed ID: 9641476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Troglitazone reduces free fatty acid-induced insulin resistance in perfused rat hindquarter.
    Mokuda O; Sakamoto Y
    Diabetes Metab; 1998 Sep; 24(4):362-4. PubMed ID: 9805648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term cardiovascular effects of insulin sensitizer troglitazone on non-diabetic individuals with insulin resistance: double blind, prospective randomized study.
    Stakos DA; Schuster DP; Sparks EA; Wooley CF; Osei K; Boudoulas H
    J Cardiol; 2003 Apr; 41(4):183-90. PubMed ID: 12728539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.